Screener
Recursion Pharmaceuticals, Inc. RXRX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Intangible assets, net | 282,888 | 309,903 |
| Goodwill | 160,350 | 162,158 |
| Deferred tax assets | 957 | 957 |
| Other assets, non-current | 12,186 | 12,754 |
| Total assets | $1,212,668 | $1,474,130 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $12,672 | $18,118 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s other non-current assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported other non-current assets of $12.19M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s other non-current assets increased by 29.4% year-over-year, from $9.42M to $12.19M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s other non-current assets has grown at a 81.4% compound annual growth rate (CAGR), from $650K to $12.75M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Recursion Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude